Market revenue in 2023 | USD 50.0 million |
Market revenue in 2030 | USD 94.4 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Infectious Diseases |
Historical data | 2021 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Infectious Diseases |
Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Mexico mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
Mexico is considered one of the most lucrative markets for R&D activities owing to the presence of skilled professionals, an increasing number of clinical research centers, and proximity to the U.S. The country provides a favorable environment to attract R&D investments, thereby stimulating the demand for CDMOs.
In addition, the availability of a diverse patient pool is one of the major drivers of the market. Moreover, the government also promotes R&D, which is expected to contribute to mRNA therapeutics contract development & manufacturing organization (CDMO) market growth.
The country has witnessed a significant rise in investment from several companies, with local and foreign investors actively participating in the market due to the developing economy. Moreover, the low operational cost in the country is anticipated to boost the market in Mexico. Furthermore, growing innovation by manufacturers is anticipated to further impel market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account